Ticker Details
STAAR Surgical Company Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses and delivery systems for the eye. The Company develops, produces, and markets intraocular lenses.
IPO Date:	March 2, 1992
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$1.62B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.56 | 2.47%
Avg Daily Range (30 D):	$0.70 | 2.49%
Avg Daily Range (90 D):	$0.56 | 2.58%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.86M
Avg Daily Volume (90 D):	1.11M

Trade Size
Avg Trade Size (Sh.):	79
Avg Trade Size (Sh.) (30 D):	57
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	3,953
Avg Institutional Trade:	$2.7M
Avg Institutional Trade (30 D):	$2.67M
Avg Institutional Trade (90 D):	$2.2M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.34M
Avg Closing Trade (30 D):	$3.21M
Avg Closing Trade (90 D):	$2.83M
Avg Closing Volume:	74.15K

News

Apr 9, 2026 @ 7:35 AM Why Did STAAR Surgical (STAA) Stock Jump 20% After... Source: Mohd Haider

Mar 17, 2026 @ 1:04 PM LENSAR Stock Plunges—Alcon Scraps Merger Af... Source: Vandana Singh

Feb 18, 2026 @ 10:18 AM FDA Expands Approval For Staar Surgical's Popular ... Source: Vandana Singh

Jan 15, 2026 @ 6:06 PM STAAR Surgical Stock Falls After Largest Sharehold... Source: Vandana Singh

Jan 14, 2026 @ 3:00 PM LASIK Eye Surgery Market Size to Reach USD 3.77 Bi... Source: Sns Insider

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS		$.1	$-.36
Diluted EPS		$.1	$-.36
Revenue		$93.52M	$57.8M
Gross Profit		$68.86M	$43.74M
Net Income / Loss		$5.21M	$-18.31M
Operating Income / Loss		$7.98M	$-22.84M
Cost of Revenue		$24.66M	$14.06M
Net Cash Flow		$-21.29M	$-23.01M
PE Ratio